Joseph Grosso

Joseph Grosso is an accomplished professional in the field of oncology and immunology, currently serving as the VP, Program Development Team Lead at Merus N.V. since May 2023. With extensive experience in clinical development and biomarker research, Joseph has held strategic roles at various organizations, including serving as a Board Member at Gift of Life Biologics and as Vice President, Translational Oncology at Transition Bio, Inc. Previous positions at Bristol Myers Squibb included leading several clinical programs in immuno-oncology and serving as Study Director focused on innovative clinical trials. Joseph's academic background includes a Ph.D. in Microbiology and Immunology from the University of Miami Miller School of Medicine.